Phase I trial of subretinal injection of a recombinant adeno-associated virus (rAAV2-VMD2-hMERTK) gene vector to patients with MERTK RP

LAUR Repository

Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Search LAUR

Advanced Search


My Account